EUVIMEDEUVIMED entdecken
Crossref

E3 ubiquitin ligase SYVN1 promotes the malignant phenotype of A549 cells by upregulating GATA3 expression via NRP1

Shan Wang, Suli Lu, Zhen Wang, Guiping Xuan, Jianhua Tan

In Vitro Cellular & Developmental Biology - Animal · 18.08.2026

DOI: 10.1007/s11626-026-01235-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift In Vitro Cellular & Developmental Biology - Animal, online erschienen am 18.08.2026. Verfasst von Shan Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Hunan Polytechnic of Environment and Biology, Hengyang, 421000, Hunan, China. Die Arbeit nennt 36 Literaturangaben. Gefördert von: Natural Science Foundation of Hunan Province, Science Popularization Special Project of Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung cancer remains one of the most lethal and prevalent malignancies worldwide. Although E3 ubiquitin ligase SYVN1 is frequently amplified in lung cancer, its functional role has not been fully elucidated. This study investigates the mechanistic involvement of SYVN1 in regulating the GATA3/NRP1 axis in A549 cells to provide novel insights into potential therapeutic strategies for lung cancer. Expression levels of SYVN1 were assessed in BEAS-2B, A549, NCI-H647, NCI-H2170, and NCI-H520, NCI-H69 cells. Functional assays were conducted after overexpressing or silencing SYVN1, GATA3, and/or NRP1 in A549 cells to examine their interdependent roles. The cells' proliferation, wound healing, invasion and migration abilities were evaluated through CCK-8, scratch assay and Transwell assays, respectively. The results indicated that SYVN1 was upregulated in A549 cells and significantly promoted cell proliferation, invasion, and migration. Mechanistically, SYVN1 interacted with GATA3 and regulated its ubiquitination. Knockdown of SYVN1 suppressed A549 cell proliferation, wound healing, invasion, and migration, and these effects could be reversed by overexpressing GATA3. Similarly, silencing GATA3 reduced these malignant characteristics, but these effects could be restored by overexpressing NRP1, and the knockdown of NRP1 could abrogate the tumor-promoting effects of SYVN1 overexpression. SYVN1 overexpression counteracted the inhibitory effects of NRP1 silencing on A549 tumor progression. Taken together, all these findings prove that SYVN1 could promote the malignant characteristics of A549 cells by modulating the GATA3/NRP1 axis. Thus, targeting SYVN1 could represent a promising therapeutic approach for treating lung cancer.

Schlagwörter

Stichwörter der Autor:innen

GATA3Lung cancerNRP1SYVN1Ubiquitin specific protease

Autor:innen und Institutionen

  • Hunan Polytechnic of Environment and Biology, Hengyang, 421000, Hunan, China.
  • The Second Affiliated Hospital, University of South China, No. 35 Jiefang Avenue, Hengyang, 421001, Hunan, China. 18774245502@163.com.

Förderung

  • Natural Science Foundation of Hunan Province
  • Science Popularization Special Project of Hunan Province

Zitieren

APA

Wang, S., Lu, S., Wang, Z., Xuan, G., & Tan, J. (2026). E3 ubiquitin ligase SYVN1 promotes the malignant phenotype of A549 cells by upregulating GATA3 expression via NRP1. In Vitro Cellular & Developmental Biology - Animal. https://doi.org/10.1007/s11626-026-01235-2

Vancouver

Wang S, Lu S, Wang Z, Xuan G, Tan J. E3 ubiquitin ligase SYVN1 promotes the malignant phenotype of A549 cells by upregulating GATA3 expression via NRP1. In Vitro Cellular & Developmental Biology - Animal. 2026. doi:10.1007/s11626-026-01235-2

BibTeX
@article{Wang2026,
  author = {Wang, Shan and Lu, Suli and Wang, Zhen and Xuan, Guiping and Tan, Jianhua},
  title = {E3 ubiquitin ligase SYVN1 promotes the malignant phenotype of A549 cells by upregulating GATA3 expression via NRP1},
  journal = {In Vitro Cellular & Developmental Biology - Animal},
  year = {2026},
  doi = {10.1007/s11626-026-01235-2}
}
Kostenlos starten →